drugset / Trial / NCT02184247
Bioavailability of Two Sustained-release Theophylline Products in Healthy Males
RandomizedCrossoverOpen-labelTreatment
Summary
Study to compare the bioavailability of 350 mg Bronchoretard® - a sustained-release theophylline (anhydrous) product with respect to the reference product, Theo Dur® 300 mg theophylline anhydrous (sustained-release product) by comparing the rate and extent of absorption of theophylline based on both single and multiple-dose profiles.
Timeline
- Start
- 1998-04
- Primary completion
- 1998-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Theophylline | Small molecule | 300 mg | — |
| Subject | Theophylline | Small molecule | 350 mg | — |
Indications
No indication recorded.